Tris Pharma (United States)
Institution data
| Type | COMPANY (active) |
|---|---|
| Country | Monmouth Junction, US |
| Works | 8 |
| Researchers | 18 |
| Citations | 4 |
| h-index | 1 |
| Coverage | 2005 - 2026 |
| ROR | 04wqwae75 |
| GRID | grid.510122.5 |
| OpenAlex | I4210162140 |
| Website | https://www.trispharma.com |
| Also known as | Tris Pharma (United States) |
The Economic burden of opioid-related serious adverse events and undertreatment of acute pain in the United States
Eu quero é botar meu bloco na rua
Interventions to reduce cancer screening inequities
Impact of the Covid-19 Pandemic on Patients Affected by Non-Communicable Diseases in Europe and in the USA
The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease
Assessment of Parkinson’s disease levodopa-induced dyskinesia
Economic Burden Associated with Extrapyramidal Symptoms in a Medicaid Population with Schizophrenia
Effective Exchange Rates in Britain, 1920-1930
Effective Exchange Rates in Britain, 1920-1930
Economic Burden Associated with Extrapyramidal Symptoms in a Medicaid Population with Schizophrenia
Assessment of Parkinson’s disease levodopa-induced dyskinesia
The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease
Impact of the Covid-19 Pandemic on Patients Affected by Non-Communicable Diseases in Europe and in the USA
Interventions to reduce cancer screening inequities
Eu quero é botar meu bloco na rua
The Economic burden of opioid-related serious adverse events and undertreatment of acute pain in the United States
| ARTICLE | 8 |
|---|
| 2026 | 1 |
|---|---|
| 2025 | 1 |
| 2023 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2015 | 1 |
| 2012 | 1 |
| 2005 | 1 |